Nukkleus Stock Odds of Future Stock Price Finishing Over 32.20
| NUKK Stock | USD 1.67 0.08 4.57% |
Nukkleus |
Nukkleus Target Price Odds to finish over 32.20
The tendency of Nukkleus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 32.20 or more in 90 days |
| 1.67 | 90 days | 32.20 | close to zero percent |
Based on a normal probability distribution, the odds of Nukkleus to move over $ 32.20 or more in 90 days from now is close to zero percent (This Nukkleus probability density function shows the probability of Nukkleus Stock to fall within a particular range of prices over 90 days) . Probability of Nukkleus price to stay between its current price of $ 1.67 and $ 32.20 at the end of the 90-day period is about 92.97 .
Given the investment horizon of 90 days the stock has the beta coefficient of 4.12 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Nukkleus will likely underperform. Additionally Nukkleus has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Nukkleus Price Density |
| Price |
Predictive Modules for Nukkleus
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nukkleus. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nukkleus Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nukkleus is not an exception. The market had few large corrections towards the Nukkleus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nukkleus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nukkleus within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.49 | |
β | Beta against Dow Jones | 4.12 | |
σ | Overall volatility | 0.38 | |
Ir | Information ratio | -0.01 |
Nukkleus Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nukkleus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nukkleus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nukkleus generated a negative expected return over the last 90 days | |
| Nukkleus has high historical volatility and very poor performance | |
| Nukkleus may become a speculative penny stock | |
| Nukkleus was previously known as Brilliant Acquisition Corp and was traded on NASDAQ Exchange under the symbol BRLI. | |
| Nukkleus currently holds 3.65 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 16.22 M. Net Loss for the year was (11.85 M) with loss before overhead, payroll, taxes, and interest of (661.4 K). | |
| Nukkleus has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Nukkleus Inc. issues new shares to single investor By Investing.com - Investing.com |
Nukkleus Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nukkleus Stock often depends not only on the future outlook of the current and potential Nukkleus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nukkleus' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.1 M | |
| Cash And Short Term Investments | 364 K |
Nukkleus Technical Analysis
Nukkleus' future price can be derived by breaking down and analyzing its technical indicators over time. Nukkleus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nukkleus. In general, you should focus on analyzing Nukkleus Stock price patterns and their correlations with different microeconomic environments and drivers.
Nukkleus Predictive Forecast Models
Nukkleus' time-series forecasting models is one of many Nukkleus' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nukkleus' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Nukkleus
Checking the ongoing alerts about Nukkleus for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nukkleus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nukkleus generated a negative expected return over the last 90 days | |
| Nukkleus has high historical volatility and very poor performance | |
| Nukkleus may become a speculative penny stock | |
| Nukkleus was previously known as Brilliant Acquisition Corp and was traded on NASDAQ Exchange under the symbol BRLI. | |
| Nukkleus currently holds 3.65 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 16.22 M. Net Loss for the year was (11.85 M) with loss before overhead, payroll, taxes, and interest of (661.4 K). | |
| Nukkleus has a poor financial position based on the latest SEC disclosures | |
| About 35.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Nukkleus Inc. issues new shares to single investor By Investing.com - Investing.com |
Check out Nukkleus Backtesting, Nukkleus Valuation, Nukkleus Correlation, Nukkleus Hype Analysis, Nukkleus Volatility, Nukkleus History as well as Nukkleus Performance. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.36) | Revenue Per Share 7.024 | Quarterly Revenue Growth (0.97) | Return On Assets (1.15) | Return On Equity (7.42) |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.